To investigate NLRC4 and NLRP3 inflammasomes as potential prognostic markers in glioma patients, we compared NLRP3 (Fig. 2a) or NLRC4 (Fig. 2b) expression with survival using TCGA data. The gene discussed is NLRC4; the disease is central nervous system cancer.